Octagon Capital Advisors LP Annexon, Inc. Transaction History
Octagon Capital Advisors LP
- $433 Million
- Q2 2024
A detailed history of Octagon Capital Advisors LP transactions in Annexon, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 400,000 shares of ANNX stock, worth $2.91 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
400,000
Previous 2,050,000
80.49%
Holding current value
$2.91 Million
Previous $14.7 Million
86.66%
% of portfolio
0.45%
Previous 2.3%
Shares
4 transactions
Others Institutions Holding ANNX
# of Institutions
157Shares Held
101MCall Options Held
3.73MPut Options Held
1.3M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$61.5 Million8.47% of portfolio
-
Satter Management Co., L.P.7.41MShares$53.9 Million71.21% of portfolio
-
Bvf Inc San Francisco, CA7MShares$51 Million1.05% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$48 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$46.8 Million2.05% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $347M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...